Regulatory & Legal

Surpassing 1,000 verified Trustpilot reviews, Hola Prime challenges industry norms with its radical transparency and a game-changing 1-Hour Payout model.

Las Vegas trial lawyer Robert Eglet's induction into the Trial Lawyer Hall of Fame signals a new era for the city and a legacy of corporate accountability.

The new CMS Medicare App Library is giving millions of seniors access to AI-driven health tools, but can technology bridge the gap in patient care?

Florian Frischmuth, a former Ford software leader, joins Envorso to guide clients through the complex, high-stakes shift to software-defined vehicles.

New data reveals nearly 4 in 10 women lack key vaginal bacteria linked to fertility, sparking a new conversation about an invisible factor in conception.

Verallia's new €63M hybrid furnace in Spain cuts CO2 by over 50%, signaling a major shift in the energy-intensive glass packaging industry.

Medical advances are increasing organ transplants in Quebec, but with nearly 900 people on the waiting list, experts say major systemic reform is essential.

Biopharma veteran Glenn Gormley joins Aktis's board, bringing deep ADC expertise to guide the company's next-gen radiopharmaceutical pipeline.

Allegro MicroSystems' upcoming Q4 results will be a key indicator for the auto and AI chip markets. Investors eye growth amid fierce competition.

Eshallgo Inc. executes a reverse stock split to stay on Nasdaq, but can its AI ambitions overcome deep financial struggles and investor skepticism?

GC Biopharma's new data on ALYGLO's purity profile could set a new standard for IVIG therapies, impacting patient safety in a rapidly growing market.

A new ad campaign attacks hospitals for failing to disclose prices, amplifying a DC battle as HHS Secretary Kennedy faces Congress on healthcare costs.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new ANAB accreditation for OmnexFuturepast aims to bolster trust in vehicle safety and cybersecurity across the entire automotive supply chain.

A new DNA-based method for urine drug testing promises to eliminate invasive observation, boosting accuracy while restoring patient dignity. But is it a true revolution?

A new clinical trial validates the Leva Pelvic Health System, offering a discreet, effective at-home treatment for a condition affecting millions of women.

Inventia Life Science's new RASTRUM Validated Solutions offer standardized 3D models to tackle the reproducibility crisis in pharmaceutical R&D.

Despite major cost cuts and growth in key divisions, DSS, Inc. struggles to convince Wall Street. Can a biotech spin-off finally unlock its true value?

A jury found Live Nation runs an illegal monopoly, but the company vows to fight the verdict. The ruling could reshape the live entertainment landscape.

A new partnership aims to replace endless paperwork with a 'one-tap' app, making elite athlete-led camps more accessible and manageable for families nationwide.